Endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer and dextranomer/hyaluronic acid in adults

Basit Öğe Kaydı
dc.authoridTarhan, Fatih/0000-0001-8168-0420
dc.contributor.authorTurk, Akif
dc.contributor.authorSelimoglu, Ahmet
dc.contributor.authorDemir, Kadir
dc.contributor.authorCelik, Osman
dc.contributor.authorSaglam, Erkin
dc.contributor.authorTarhan, Fatih
dc.date.accessioned2025-03-23T19:30:02Z
dc.date.available2025-03-23T19:30:02Z
dc.date.issued2014
dc.departmentSinop Üniversitesi
dc.description.abstractPurpose: Aim of this study is to examine the effectiveness of dextranomer/hyaluronic acid copolymer and polyacrylate polyalcohol copolymer in endoscopic treatment of vesicoureteral reflux disease in adult patients with and without chronic renal failure. Materials and Methods: Thirty two patients (12 female, 20 male) with a total of 50 renal units were treated for vesicoureteral reflux. There were 26 (81%) chronic renal failure patients. The success of treatment was evaluated by voiding cystouretrography at 3rd and 12th months after subureteric injection. The persistence of reflux was considered as failure. Patients were divided into two groups according to injected material. Age, sex, grade of reflux and treatment results were recorded and evaluated. Results: Reflux was scored as grade 1 in seven (14%), grade 2 in 16 (32%), grade 3 in 21 (42%) and grade 4 in six (12%) renal units. There was not patient with grade 5 reflux. Fourteen renal units (28%) were treated with dextranomer/hyaluronic acid copolymer (group 1) and 36 renal units (72%) were treated with polyacrylate polyalcohol copolymer (group 2). The overall treatment success was achieved at 40 renal units (80%). The treatment was successful at 11 renal units (79%) in group 1 and 29 renal units (81%) in group 2 (p = 0.71). There was not statistically significant difference between two groups with patients with chronic renal failure in terms of treatment success (p = 1.00). Conclusions: The effectiveness of two bulking agents was similar in treatment of vesicoureteral reflux disease in adult patients and patients with chronic renal failure.
dc.identifier.doi10.1590/S1677-5538.IBJU.2014.03.12
dc.identifier.endpage383
dc.identifier.issn1677-5538
dc.identifier.issn1677-6119
dc.identifier.issue3
dc.identifier.pmid25010304
dc.identifier.scopusqualityQ2
dc.identifier.startpage379
dc.identifier.urihttps://doi.org/10.1590/S1677-5538.IBJU.2014.03.12
dc.identifier.urihttps://hdl.handle.net/11486/4994
dc.identifier.volume40
dc.identifier.wosWOS:000345313100012
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBrazilian Soc Urol
dc.relation.ispartofInternational Braz J Urol
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250323
dc.subjectKidney Failure, Chronic
dc.subjectdextranomer [Supplementary Concept]
dc.subjectHyaluronic Acid
dc.subjectInjections
dc.subjectVesico-Ureteral Reflux
dc.titleEndoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer and dextranomer/hyaluronic acid in adults
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu